Naoki Watanabe

1.5k citations

72 papers · 1.2k indexed · h-index 21

Co-authors: Naofumi Yamauchi H Neda Masahiro Maeda Hiroshi Kuriyama Atsuhito Yagihashi I Urushizaki Hiroshi Umeno Yoshiro Niitsu
Topics: Chronic Myeloid Leukemia Treatments (14 papers)Chronic Lymphocytic Leukemia Research (9 papers)Immune Response and Inflammation (7 papers)
Cited by: Immunology Hematology Immunology and Allergy
Journals: Journal of Biological Chemistry The Journal of Experimental MedicineSHILAP Revista de lepidopterología
Partner nations: Japan United States Singapore

In The Last Decade

Naoki Watanabe

67 papers receiving 1.2k citations

Peers

Countries citing papers authored by Naoki Watanabe

Since Specialization

Citations

This map shows the geographic impact of Naoki Watanabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naoki Watanabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naoki Watanabe more than expected).

Fields of papers citing papers by Naoki Watanabe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naoki Watanabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naoki Watanabe. The network helps show where Naoki Watanabe may publish in the future.

Co-authorship network of co-authors of Naoki Watanabe

This figure shows the co-authorship network connecting the top 25 collaborators of Naoki Watanabe. A scholar is included among the top collaborators of Naoki Watanabe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naoki Watanabe. Naoki Watanabe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Outcomes of pregnancy in patients with chronic myeloid leukemia in the era of tyrosine kinase inhibitors 2024 ·Cancer ·Takeshi Kondo,Eri Matsuki,Tomoiku Takaku,Naoki Watanabe,Chikashi Yoshida,Masaya Okada,Kazunori Murai,Takashi Kodama,Naoto Takahashi,Shinya Kimura,Itaru Matsumura,(unknown)	1
2	Changes in chronic myeloid leukemia treatment modalities and outcomes after introduction of second-generation tyrosine kinase inhibitors as first-line therapy: a multi-institutional retrospective study by the CML Cooperative Study Group 2024 ·International Journal of Hematology ·Noriyoshi Iriyama,Eisaku Iwanaga,Yuta Kimura,Naoki Watanabe,Maho Ishikawa,Hitomi Nakayama,Eriko Sato,Takayuki Tabayashi,(unknown),Tomoiku Takaku,Tomonori Nakazato,Michihide Tokuhira,Hiroyuki Fujita,Miki Ando,Yoshihiro Hatta,Tatsuya Kawaguchi	2
3	Endothelial function measured by peripheral arterial tonometry in patients with chronic myeloid leukemia on tyrosine kinase inhibitor therapy: a pilot study 2023 ·Cardio-Oncology ·(unknown),Sakiko Miyazaki,(unknown),(unknown),(unknown),Naoki Watanabe,Tomoiku Takaku,Norio Komatsu,Tohru Minamino	2
4	Clinical management of second-generation tyrosine kinase inhibitor therapy in patients with newly diagnosed chronic myeloid leukemia in the chronic phase, focusing on age and dose effects 2023 ·International Journal of Hematology ·Michihide Tokuhira,Yuta Kimura,Takayuki Tabayashi,Naoki Watanabe,(unknown),Tomoiku Takaku,Noriyoshi Iriyama,Eriko Sato,Tomonori Nakazato,(unknown),Maho Ishikawa,Hiroyuki Fujita,Masahiro Kizaki,Miki Ando,Yoshihiro Hatta,Eisaku Iwanaga,Tatsuya Kawaguchi	1
5	Management and Risk Factors for Pleural Effusion in Japanese Patients with Chronic Myeloid Leukemia Treated with First-line Dasatinib in Real-world Clinical Practice 2023 ·Internal Medicine ·(unknown),Tomoiku Takaku,Naoki Watanabe,Noriyoshi Iriyama,Yuta Kimura,Eisaku Iwanaga,Keiji Sugimoto,(unknown),Maho Ishikawa,Tomonori Nakazato,Hiroyuki Fujita,Eriko Sato,Yoshihiro Hatta,Norio Asou,(unknown),Michihide Tokuhira,Miki Ando,Tatsuya Kawaguchi	1
6	Persistent COVID-19 Pneumonia and Failure to Develop Anti-SARS-CoV-2 Antibodies During Rituximab Maintenance Therapy for Follicular Lymphoma 2020 ·Clinical Lymphoma Myeloma & Leukemia ·Hajime Yasuda,(unknown),Naoki Watanabe,(unknown),(unknown),(unknown),(unknown),Yusuke Ochi,Norio Komatsu	58
7	Acquired Factor VIII Inhibitor in a Patient of Rheumatoid Arthritis on Tumor Necrosis Factor Inhibitor Therapy 2018 ·Indian Journal of Hematology and Blood Transfusion ·(unknown),Naoki Watanabe,Hideaki Kitahara,(unknown),Michiaki Koike,Norio Komatsu	0
8	Richter’s Syndrome with Hypercalcemia Induced by Tumor-Associated Production of Parathyroid Hormone-Related Peptide 2017 ·Case Reports in Oncology ·Naoki Watanabe,Hajime Yasuda,Soji Morishita,(unknown),Junichi Tomomatsu,Masaru Tanaka,Akimichi Ohsaka,Norio Komatsu	6
9	Overexpression of serine threonine tyrosine kinase 1/novel oncogene with kinase domain mRNA in patients with acute leukemia 2009 ·Experimental Hematology ·Takashi Kondoh,Daisuke Kobayashi,Naoki Tsuji,Kageaki Kuribayashi,Naoki Watanabe	17
10	A CASE OF NON-RECURRENT AND RECURRENT INFERIOR LARYNGEAL NERVE IDENTIFIED DURING HEMI-THYROIDECTOMY FOR THYROID FOLLICULAR ADENOMA 2007 ·Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) ·Naoki Watanabe,(unknown)	1
11	PROTECTIVE MECHANISM OF β-SQAG9 LIPOSOME, A SULFONOGLYCOLIPID EXTRACTED FROM SEA URCHIN INTESTINES, AGAINST HEPATIC ISCHEMIA REPERFUSION INJURY 2007 ·Shock ·Hiroaki Shima,Tetsuhiro Tsuruma,Hiroeki Sahara,(unknown),Nobuaki Takahashi,(unknown),Atsuhito Yagihashi,Naoki Watanabe,Noriyuki Sato,Koichi Hirata	1
12	Survivin enhances telomerase activity via up-regulation of specificity protein 1- and c-Myc-mediated human telomerase reverse transcriptase gene transcription 2005 ·Experimental Cell Research ·(unknown),Naoki Tsuji,Koichi Asanuma,Atsuhito Yagihashi,Naoki Watanabe	71
13	Cryptic insertion and translocation or nondividing leukemic cells disclosed by FISH analysis in infant acute leukemia with discrepant molecular and cytogenetic findings 2003 ·Leukemia ·Naoki Watanabe,Hirofumi Kobayashi,(unknown),M. Yoshida,Atsushi Kikuta,Yoshihiro Komada,Ichiro Sekine,Yasushi Ishida,(unknown),Yukiko Tsunematsu,Michihiro Yano,Hisaya Nakadate,Yasuhiko Kaneko	22
14	Gene Expression for Suppressors of Telomerase Activity (Telomeric‐repeat Binding Factors) in Breast Cancer 2002 ·Japanese Journal of Cancer Research ·Kaori Saito,Atsuhito Yagihashi,(unknown),(unknown),Masashi Nakamura,Daisuke Kobayashi,Naoki Tsuji,Naoki Watanabe	31
15	Limitations of urinary telomerase activity measurement in urothelial cancer 2000 ·Clinica Chimica Acta ·Yoshio Arai,Tomomi Yajima,Atsuhito Yagihashi,Daisuke Kobayashi,Hidekazu Kameshima,Masahiro Sasaki,Keiko Tanaka,(unknown),(unknown),(unknown),Naoki Watanabe	17
16	Role of Human Telomerase Reverse Transcriptase and Telomeric‐repeat Binding Factor Proteins 1 and 2 in Human Hematopoietic Cells 2000 ·Japanese Journal of Cancer Research ·Koji Yamada,Tomomi Yajima,Atsuhito Yagihashi,Daisuke Kobayashi,(unknown),Koichi Asanuma,M Yamada,Ryosuke Moriai,Hidekazu Kameshima,Naoki Watanabe	21
17	Ceftizoxime‐induced hemolysis due to immune complexes: case report and determination of the epitope responsible for immune complex‐mediated hemolysis 1999 ·Transfusion ·(unknown),Atsuhito Yagihashi,M. Sasaki,Naoki Watanabe	17
18	A Delayed Hemolytic Transfusion Reaction (DHTR) with Multiple Alloantibodies (Anti-E, Jk^a, Di^a, Fy^b, and S) Induced by E-Antigen-Negative, Crossmatch-Compatible Blood 1998 ·Immunopharmacology and Immunotoxicology ·K Yamane,(unknown),Makoto Sasaki,(unknown),(unknown),Naoki Watanabe	7
19	Downregulation of Cytokine-induced Neutrophil Chemoattractant and Prolongation of Rat Liver Allograft Survival by Interleukin-10 1998 ·Surgery Today ·(unknown),Atsuhito Yagihashi,Koichi Hirata,(unknown),Takashi Matsuno,(unknown),Koichi Asanuma,Naoki Watanabe	25
20	Postinfantile giant cell hepatitis accompanied by hypereosinophilia. 1994 ·Kanzo ·(unknown),Shuichi Nojiri,Yasuhiro Nagamachi,Kazuhiko Koike,Naoki Watanabe,Yutaka Kohgo,(unknown),Miri Fujita,Kazuo Nagashima,Yoshiro Niitsu	0

About Naoki Watanabe

Naoki Watanabe is a scholar working on Hematology, Genetics and Immunology, having authored 72 papers that have together received 1.2k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (14 papers), Chronic Lymphocytic Leukemia Research (9 papers) and Immune Response and Inflammation (7 papers). The work is most often cited by research in Immunology (380 citations), Hematology (152 citations) and Immunology and Allergy (72 citations). Naoki Watanabe has collaborated with scholars based in Japan, United States and Singapore. Frequent co-authors include Naofumi Yamauchi, H Neda, Masahiro Maeda, Hiroshi Kuriyama, Atsuhito Yagihashi, I Urushizaki, Hiroshi Umeno, Yoshiro Niitsu, Naoki Tsuji and Daisuke Kobayashi. Their work appears in journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact